Atlas Trials

BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx

Clinical trial NCT02038010 · COMPLETED

Trial details

NCT number
NCT02038010
Sponsor
Northwestern University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HER2-positive Breast CancerRecurrent Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast Cancer
Start date
2014-05-21
Primary completion
2015-04-15
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.